Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies DOI Creative Commons

Annapaola Montagner,

Andrea Arleo, Fabrizia Suzzi

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(12), P. 1581 - 1581

Published: Dec. 11, 2024

Immunotherapy has shown significant improvement in the survival of patients with hepatocellular carcinoma (HCC) compared to TKIs as first-line treatment. Unfortunately, approximately 30% HCC exhibits intrinsic resistance ICIs, making new therapeutic combinations urgently needed. The dysregulation Notch signaling pathway observed can affect immune cell response, reducing efficacy cancer immunotherapy. Here, we provide an overview how regulates responses and present rationale for combining inhibition ICIs improve Moreover, propose using exosomes non-invasive tools assess activation hepatic cells, enabling accurate stratification who benefit from combined strategies.

Language: Английский

Exploring the phytochemical profile, antioxidant activity, and anticancer potential of Achillea millefolium extracts: In-vitro and in-silico investigation DOI

Asia Kiran,

Awais Altaf,

Muhammad Sarwar

et al.

South African Journal of Botany, Journal Year: 2025, Volume and Issue: 177, P. 684 - 698

Published: Jan. 9, 2025

Language: Английский

Citations

1

IGF2BP1/AIFM2 axis regulates ferroptosis and glycolysis to drive hepatocellular carcinoma progression DOI
Wei Peng, Jie Liang,

Xuanlv Qian

et al.

Cellular Signalling, Journal Year: 2025, Volume and Issue: unknown, P. 111660 - 111660

Published: Feb. 1, 2025

Language: Английский

Citations

1

Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions DOI
Michael Mohnasky,

Sandra Gad,

Andrew M. Moon

et al.

Journal of the American College of Radiology, Journal Year: 2025, Volume and Issue: 22(3), P. 260 - 268

Published: March 1, 2025

Language: Английский

Citations

1

Liposomes and Niosomes: New trends and applications in the delivery of bioactive agents for cancer therapy DOI
Helena de Almeida Cerqueira Kodel,

Paria Alizadeh,

Samad Nejad Ebrahimi

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 124994 - 124994

Published: Nov. 1, 2024

Language: Английский

Citations

4

All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement DOI Open Access
Carolina Lanza, Velio Ascenti, Gaetano Amato

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(2), P. 314 - 314

Published: Jan. 7, 2025

Transcatheter arterial chemoembolization (TACE) is a proven and widely accepted treatment option for hepatocellular carcinoma it recommended as first-line non-curative therapy BCLC B/intermediate HCC (preserved liver function, multifocal, no cancer-related symptoms) in patients without vascular involvement. Different types of TACE are available nowadays, including TAE, c-TACE, DEB-TACE, DSM-TACE, but at present there insufficient evidence to recommend one technique over another the choice left operator. This review then aims provide comprehensive overview current literature on indications, procedures, safety, efficacy different treatments.

Language: Английский

Citations

0

Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies DOI
Sunil Kumar Sah,

Sama Ajay,

Asawari Dilip Donadkar

et al.

International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125261 - 125261

Published: Jan. 1, 2025

Language: Английский

Citations

0

Minimally invasive versus Open liver resection for nonmetastatic Hepatocellular Carcinoma staged BCLC - B and - C: an Italian multicentric analysis DOI
Gianluca Cassese, Mariano Cesare Giglio, Alessandro Vitale

et al.

HPB, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Impact of bridge therapy for hepatocellular carcinoma in patients submitted to liver transplantation: A Brazilian multicenter study DOI Creative Commons

Júlia Fadini Margon,

Aline Lopes Chagas, Ângelo Alves de Mattos

et al.

Journal of Liver Transplantation, Journal Year: 2025, Volume and Issue: unknown, P. 100258 - 100258

Published: Jan. 1, 2025

Language: Английский

Citations

0

HTRecNet: a deep learning study for efficient and accurate diagnosis of hepatocellular carcinoma and cholangiocarcinoma DOI Creative Commons
Jingze Li,

Yupeng Niu,

Jiang Du

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 13

Published: March 24, 2025

Background Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) represent the primary liver cancer types. Traditional diagnostic techniques, reliant on radiologist interpretation, are both time-intensive often inadequate for detecting less prevalent CCA. There is an emergent need to explore automated methods using deep learning address these challenges. Methods This study introduces HTRecNet, a novel framework enhanced precision efficiency. The model incorporates sophisticated data augmentation strategies optimize feature extraction, ensuring robust performance even with constrained sample sizes. A comprehensive dataset of 5,432 histopathological images was divided into 5,096 training validation, 336 external testing. Evaluation conducted five-fold cross-validation applying metrics such as accuracy, area under receiver operating characteristic curve (AUC), Matthews correlation coefficient (MCC) against established clinical benchmarks. Results validation cohorts comprised 1,536 normal tissue, 3,380 HCC, 180 HTRecNet showed exceptional efficacy, consistently achieving AUC values over 0.99 across all categories. In testing, reached accuracy 0.97 MCC 0.95, affirming its reliability in distinguishing between normal, CCA tissues. Conclusion markedly enhances capability early accurate differentiation HCC from Its high efficiency position it invaluable tool settings, potentially transforming protocols. system offers substantial support refining workflows healthcare environments focused malignancies.

Language: Английский

Citations

0

Oxidative Imbalance Linked to Impaired Mitochondrial Bioenergetics Mediates the Toxicity of Mesoionic Compounds MI-D and MI-J in Hepatocarcinoma Cells (HepG2) DOI

Ana Paula Neves,

Fernando Diego Kaziuk,

Marília Locatelli Corrêa-Ferreira

et al.

Free Radical Research, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 12

Published: March 25, 2025

Hepatocellular carcinoma (HCC) is a common and deadly form of liver cancer with limited treatment options for advanced stages. Mesoionic compounds MI-D MI-J have shown potential treating HCC due to their significant toxicity these cells. This study investigated whether this linked effects on oxidative balance in HepG2 cells cultured high glucose (HG-glycolysis-dependent) galactose plus glutamine supplemented (GAL- phosphorylation-dependent) DMEM medium. ROS levels were increased both media when exposed (50 μM). However, at an intermediate concentration (25 μM) decreased the GAL Superoxide dismutase (SOD) activity under all tested conditions by Conversely, total peroxidase 25 50 μM, respectively. HG medium glutathione (GPX) activity, whereas reduced enzyme μM it μM. In medium, GPx while reductase (GR) was media. Furthermore, P-AMPK/tAMPk ratio Our results show that caused imbalance, particularly affecting The data also support mesoionic depended substituent ring.

Language: Английский

Citations

0